Posts Tagged ‘prices

September 28, 2020
Our Take: The Darwin Value Index
Read More
September 21, 2020
Our Take: MSSP generated net savings of $1.2 billion for Medicare in 2019
Read More
September 14, 2020
Our Take: Drug execs, public health officials try to shore up confidence in safety of future COVID-19 vaccine
Read More
August 31, 2020
Our Take: CDC changes COVID-19 testing guidance, FDA issues EUA for convalescent plasma; both agencies face backlash
Read More
August 24, 2020
Our Take: Big-name drugmakers make billion-dollar deals; digital ‘unicorn’ once worth $1.5 billion goes for $15 million
Read More
August 17, 2020
Our Take: As federal funding shores up for-profit health systems’ finances, lower utilization increases profits for Kaiser Permanente and top insurers
Read More
August 10, 2020
Our Take: Trump’s executive order, CMS’ proposed payment rules offer hope to rural areas
Read More
August 03, 2020
Our Take: Late-stage trials of COVID-19 vaccine candidates get underway as BARDA agrees to additional funding for vaccine development, production
Read More
July 27, 2020
Our Take: Trump renews efforts to lower drug prices ahead of election
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Copyright © 2024 Darwin Research Group Inc.

Stay Connected